Cardiff Oncology, Inc. (CRDF)
3.18
+0.27
(+9.28%)
USD |
NASDAQ |
Dec 24, 12:59
3.185
0.00 (0.00%)
After-Hours: 13:59
Cardiff Oncology SG&A Expense (TTM): 14.24M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Agenus, Inc. | 63.03M |
| AIM ImmunoTech, Inc. | 10.06M |
| Perspective Therapeutics, Inc. | 31.53M |
| Protalix Biotherapeutics, Inc. | 11.16M |
| Armata Pharmaceuticals, Inc. | 12.31M |